M&A / Growth Strategy guide
Healthcare M&A coverage on this site is organized around the decisions owners and operators face: whether and how to sell or partner, what moves value, how platforms and add-ons differ, and which regulators now expect notice before a deal closes. Start with the question closest to yours. Each pick is an HGS summary of a published source, with the source linked and dated. The full archive, newest first, follows below.
Preparing for a sale or a partner
Before talking to buyers, compare the paths: a full sale, a partnership or joint venture, or staying independent and growing through tuck-ins.
What drives valuation
Pricing conversations often turn on earnings quality, revenue cycle performance and how standardized operations are. Read deal-market data as context, not as a quote for your practice.
Platform or add-on: where consolidation is happening
Platforms set the operating model and add-ons plug into it. Track who is buying and where they are building to see where a practice might fit.
Regulatory review and notice laws
State notice laws and federal attention to MSO and antitrust questions are adding review steps to some deals, as the posts below describe. Build that time into the timeline.
Tool: Practice Valuation Calculator: a directional enterprise-value range from adjusted EBITDA and the drivers buyers weigh. Educational, not an appraisal.
Picks reviewed October 2026.
All posts, newest first
-
Six dental leaders told Becker’s Dental Review that DSOs are likely to build more new locations over the next two years, but selectively rather than as a replacement…
-
CMS’s 2027 Home Health Prospective Payment System final rule lets the agency deny or revoke Medicare enrollment over violations by a provider’s owners or parent companies, not only…
-
A Health Affairs study of 191 for-profit hospices acquired by private equity firms between 2018 and 2022 found higher Medicare spending per hospice encounter after acquisition than at…
-
Private equity owned 561 U.S. hospitals, or 11.9% of private hospitals, in the Private Equity Stakeholder Project’s fall 2026 tracker update, up from 447 hospitals and 9.5% in…
-
Levin Associates counted 105 physician medical group transactions in the third quarter of 2026, according to an Oct. 19 news release reported by Becker’s ASC Review. That is…
-
Becker’s Hospital Review counted 38 hospital mergers and acquisitions completed in 2026 in its Oct. 16 update, listed from Oct. 1 back to Jan. 1. Six deals closed…
-
Independent physician practices have at least four growth paths besides selling to private equity, according to a Fierce Healthcare Industry Voices column by Pullman & Comley health care…
-
Heartland Dental grew toward 2,000 supported offices by screening every deal on the doctor first, then the facility, then the market, and only then the financials. Chief Growth…
-
Healthcare M&A stayed steady in Q3 2026, but physician practice management (PPM) deals slightly declined as state corporate-practice-of-medicine and “mini-HSR” transaction-notice laws lengthened timelines and higher financing costs…
-
Private equity deal count in healthcare services is on pace for its lowest level since 2017, with PitchBook projecting 674 deals annualized versus a 2018-2024 average of 903….